GCTK

GlucoTrack, Inc. GCTK

GCTK
GlucoTrack, Inc. BBLG
Bone Biologics Corporation NDRA
ENDRA Life Sciences Inc. AKAN
Akanda Corp. DHAI
DIH Holding US, Inc. RDHL
RedHill Biopharma Ltd. INM
InMed Pharmaceuticals Inc. BGMS
Bio Green Med Solution, Inc. NAOV
NanoVibronix, Inc. VERO
Venus Concept Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode GCTK BBLG NDRA AKAN DHAI RDHL INM BGMS NAOV VERO
6M -27.70 % -67.21 % 47.40 % -86.06 % -99.98 % -40.72 % -68.22 % -76.41 % -69.04 % -20.00 %
YTD -98.82 % -69.10 % -20.81 % -90.10 % -100.00 % -82.03 % -74.38 % -76.41 % -95.79 % -59.35 %
1Y -98.55 % -66.30 % -4.85 % -89.14 % -100.00 % -81.89 % -73.61 % -76.41 % -95.13 % -55.56 %
3Y -99.95 % -98.71 % -99.94 % -99.85 % -100.00 % -99.17 % -95.44 % -76.41 % -99.52 % -96.26 %
5Y -99.98 % -99.95 % -99.98 % -100.00 % -100.00 % -99.99 % -99.92 % -76.41 % -99.84 % -99.42 %
10Y -100.00 % -99.95 % -100.00 % -100.00 % -100.00 % -99.99 % -99.94 % -76.41 % -99.97 % -99.99 %
From the beginning -100.00 % -99.95 % -100.00 % -100.00 % -100.00 % -99.99 % -99.97 % -76.41 % -99.96 % -99.99 %

Dividend